Tag archive for ‘Israeli Andromeda Biotech’
Jewish Business News On Thursday, April 24th, 2014

Hyperion Therapeutics acquires Israeli Andromeda Biotech for up to $570 million

– Hyperion Therapeutics (Nasdaq:HPTX) announced today that it acquires Andromeda Biotech Ltd., an Israel-based subsidiary of Clal Biotechnology Industries Ltd. (TASE:CBI), for $20 million in cash More...

Wordpress site Developed by Fixing WordPress Problems